+3 8(066) 185-39-18
fПредмет:
Тип роботи:
Дипломна робота
К-сть сторінок:
52
Мова:
Українська
the mumps virus / B. Cristenson, M. Böttiger // Biogicals. – 1990. – Vol. 18. – P. 213 – 219.
36. Cristofari G., Ivanyi-Nagy R., Gabus C. The hepatitis C virus Core protein is a potent nucleic acid chaperone that directs dimerization of the viral (+) strand RNA in vitro / G. Cristofari, R. Ivanyi-Nagy, C. Gabus // Nucleic Acids Res. – 2004. – Vol. 32. – P. 262 – 231.
37. Dayan G. H. Mumps outbreaks in vaccinated populations; are available mumps vaccine effective enough to prevent outbreaks? / G. H. Dayan, S. Rubin // Clin. Infect. Dis. – 2008. – Vol. 47. – P. 1458 – 1467.
38. Dudarev M. Prevalence of scrum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan Children, in the context of vaccine vector efficacy. / M. Dudarev, L. Andrews, S. C. Gilbern // Vaccine – 2009. – Vol. 27. – №27. – P. 3501-3504.
39. Fromentin R. A method for in vitro assembly of hepatitis C virus core protein and for screening of inhibitors / R. Fromentin, N. Majeau, M. E. Laliberte Gagne // Anal. Biochem. – 2007. – Vol. 366. – P. 37 – 45.
40. Hanna – Wakima R. Immune responses to mumps vaccine in adults who were vaccinated in child-hood / R. Hanna – Wakima, L. L. Yasukawa, P. Sung // J. Infect. Dis. – 2008. – № 12. – P. 1669 – 1675.
41. Houghton M. Prospects for a vaccine against the hepatitis C virus / M. Houghton, S. Abrignani // Nature. – 2005. – Vol. 436. – P. 961 – 966.
42. Hussy P. Hepatitis C virus core protein: carboxy- terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase / P. Hussy, H. Langen, J. Mous // Virology. – 1996. – Vol. 224. – P. 104 – 193.
43. Kunkel M. Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein / M. Kunkel, M. Lorinczi, R. Rijnbrand // J. Virol. – 2001. – Vol. 75. – P. 211 – 229.
44. Langermans J. A. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. / J. A. Langermans, T. M. Doherty, R. A. Vervenne // Vaccine. – 2005. – Vol. 23. – P. 2740 – 2750.
45. Lo S. Y. Differential subcellular localization of hepatitis C virus core gene products / S. Y. Lo, F. Masiarz, S. B. Hwang // Virology. – 1995. – Vol. 213. – P. 455 – 461.
46. McConnell M. J. Biology of adenovirus and its use asavectorfor gene therapy / M. J. McConnell, J. M. Impcriale // Hum. Gene. Ther. – 2004. – Vol. 15. – P. 1022 – 1033.
47. Mossong J. Seroprevalence of measles, mumps and rubella antibodies in Luxemburg: results from a national crosssectional study / J. Mossong, L. Putz, F. Schneider // Epidemiol. Infect. – 2003. – Vol. 132. – P. 11 – 18.
48. Munsen Kh. Prevalence of mumps antibodies in the Israeli population in relation to mumps vaccination policy and incidence of disease / Kh. Munsen, Y. Aboudy, E. Mendelson, M. S. Green, D. Cohen // Epidemiol. Infect. – 2008. – Vol. 136. – P. 688 – 693.
49. Norman G. R. Biostatistics. The bare essentials / G. R. Norman, D. L. Streiner // – 2nd Ed. – London, 2000. – 641 p.
50. Pipkin P. A. Assay of humoral immunity to mumps virus / P. A. Pipkin, M. A. Afzal, A. B. Heath // J. Virol. Meth. – 1999. – Vol. 79. – P. 219 – 225.
51. Rubin S. A. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus assiciated with a large outbreak / S. A. Rubin, L. Qi, S. A. Audet // J. Infect. Dis. – 2008. – Vol. 198. – № 4. – P. 508 – 515.
52. Rubin S. Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains / S. Rubin, J. Mauldin, K. Chumakov // Vaccine. – 2006. – Vol. 24. – P. 2662 – 2668.
53. Santolini E. Biosynthesis and biochemical properties of the hepatitis C virus core protein / E. Santolini, G. Migliaccio, N. La Monica // J. Virol. – 1994. – Vol. 68. – P. 341 – 363.
54. Santangelo M. P. Mycobacterium bovis BCG as a denverysystem for the RAP-1 antigen from Babesia bovis. / M. P. Santangelo, D. McIntosh, F. Bigi //Vaccine. – 2007. – Vol. 25. – P. 1104-1113.
55. Schuttler C. G. Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein / C. G. Schuttler, N. Fiedler, K. Schmidt // J. Hepatol. – 2002. – Vol. 37. – P. 62 – 85.
56. Schwer B. Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif / B. Schwer, S. Ren, T. Pietschmann // J. Virol. – 2004. – Vol. 78. – P. 768 – 795.
57. Siavoshian S. Hepatitis C virus core, NS3, NS5A, NS5B proteins induce apoptosis in mature dendritic cells / S. Siavoshian, J. D. Abraham, C. Thumann, M. P. Kieny, C. Schuster // J Med Virol. – 2005. – Vol. 75. – P. 402 – 411.